| Gynecologic cancers and non-coding RNAs: epigenetic regulators with emerging roles ZS Razavi, V Tajiknia, S Majidi, M Ghandali, HR Mirzaei, N Rahimian, ... Critical reviews in oncology/hematology 157, 103192, 2021 | 106 | 2021 |
| Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers M Hashemipour, H Boroumand, S Mollazadeh, V Tajiknia, ... Gynecologic oncology 161 (1), 314-327, 2021 | 71 | 2021 |
| Cell death pathways and viruses: role of microRNAs JS Nahand, L Shojaie, SA Akhlagh, MS Ebrahimi, HR Mirzaei, HB Baghi, ... Molecular Therapy-Nucleic Acids 24, 487-511, 2021 | 67 | 2021 |
| Long‐term side effects and lingering symptoms post COVID‐19 recovery M Zarei, D Bose, M Nouri‐Vaskeh, V Tajiknia, R Zand, M Ghasemi Reviews in medical virology 32 (3), e2289, 2022 | 66 | 2022 |
| Use of Salmonella Bacteria in Cancer Therapy: Direct, Drug Delivery and Combination Approaches F Badie, M Ghandali, SA Tabatabaei, M Safari, A Khorshidi, ... Frontiers in Oncology 11, 624759, 2021 | 51 | 2021 |
| Therapeutic targeting of TRAIL death receptors F Di Cristofano, A George, V Tajiknia, M Ghandali, L Wu, Y Zhang, ... Biochemical Society Transactions 51 (1), 57-70, 2023 | 26 | 2023 |
| Role of MRI in Pre-operative Assessment of patients with Advanced ovarian cancer candidate for cytoreductive surgery, A Brief Review V Tajiknia, S Hassani, H Seifmanesh, A Afrasiabi, H Hosseinpour J. Obstetrics Gynecology and Reproductive Sciences 5 (9), 2021 | 24 | 2021 |
| An update on the effects of probiotics on gastrointestinal cancers A Davoodvandi, F Fallahi, OR Tamtaji, V Tajiknia, Z Banikazemi, ... Frontiers in pharmacology 12, 680400, 2021 | 23 | 2021 |
| Aquaporin 4 and brain-related disorders: Insights into its apoptosis roles E Dadgostar, V Tajiknia, N Shamsaki, M Naderi-Taheri, M Aschner, ... Excli Journal 20, 983, 2021 | 9 | 2021 |
| Targeting apoptotic pathways for cancer therapy X Tian, PR Srinivasan, V Tajiknia, AFSS Uruchurtu, AA Seyhan, ... The Journal of clinical investigation 134 (14), 2024 | 6 | 2024 |
| Combination of 5-FU plus KRAS G12D inhibitor MRTX1133 against human colorectal and pancreatic cancer cells and the affects on inhibition of pERK and immune-stimulatory cytokine … V Tajiknia, WS El-Deiry, M Schwermann, K Huntington, L Zhou, ... Journal of Clinical Oncology 41 (16_suppl), e16301-e16301, 2023 | 5 | 2023 |
| Integrin ɑvβ6 upregulation as a mechanism of T-cell evasion in head and neck squamous cell carcinoma WJ MacDonald, PR Srinivasan, M Pinho-Schwermann, S Zhang, ... Cancer Research 84 (6_Supplement), 6528-6528, 2024 | 1 | 2024 |
| ITGB6 as a predictive biomarker for overall prognosis and PD-(L) 1 immune checkpoint blockade response in various cancer types WJ MacDonald, PR Srinivasan, M Pinho-Schwermann, V Tajiknia, ... Cancer Research 84 (6_Supplement), 5140-5140, 2024 | 1 | 2024 |
| Androgen receptor signaling blockade enhances NK cell-mediated killing of prostate cancer cells and sensitivity to NK cell checkpoint blockade M Pinho-Schwermann, BA Carneiro, L Carlsen, KE Huntington, ... bioRxiv, 2023.11. 15.567201, 2023 | 1 | 2023 |
| Combination of 5-Fluorouracil or ONC212 plus KRAS G12D inhibitor MRTX1133 against colorectal and pancreatic cancer cells results in immune-stimulatory cytokine patterns and … V Tajiknia, W El-Deiry, MP Schwermann, L Zhou, K Huntington Cancer Research 83 (7_Supplement), 1072-1072, 2023 | 1 | 2023 |
| A brief review on Covid-19 and flavonoids antiviral effects V Tajiknia J Corona Virus 1 (3), 1-4, 2021 | 1 | 2021 |
| Giant solitary fibrous tumor of the liver, case report: Unusual site, extravagant presentation, aggressive behavior B Farazmand, H Fahimi, V Tajiknia, N Tajiknia Academic Journal of Surgery 4 (2), 58-60, 2017 | 1 | 2017 |
| Synergistic anti-tumor activity, reduced pERK, and immuno-stimulatory cytokine profiles with 5-FU or ONC212 plus KRAS G12D inhibitor MRTX1133 in CRC and pancreatic cancer cells … V Tajiknia, M Pinho-Schwermann, PR Srinivasan, LH Borrero, L Zhang, ... American Journal of Cancer Research 14 (9), 4523, 2024 | | 2024 |
| ITGB6 as an inhibitor of T-cell killing via modulation of paracrine TGFβ signaling in pancreatic ductal adenocarcinoma. WJ MacDonald, M Schwermann, P Srinivasan, V Tajiknia, WS El-Deiry Journal of Clinical Oncology 42 (16_suppl), e16334-e16334, 2024 | | 2024 |
| Co-treatment of human GBM cell lines with imipridone ONC206 and tumor treating fields: Effect on on cell death and p-AKT. V Tajiknia, WS El-Deiry, M Schwermann, WJ MacDonald, N Stubbs Journal of Clinical Oncology 42 (16_suppl), e14033-e14033, 2024 | | 2024 |
Wafik El-DeiryAssociate Dean, Warren Alpert Medical School, Brown University在 brown.edu 的电子邮件经过验证
